股東應立即聯繫該公司，因為可能有限的時間來維護您的權利。
, /PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否可能違反聯邦證券法和/或對股東的信託責任。
Barinthus Biotherapeutics plc (NASDAQ: BRNS) 與 Clywedog Therapeutics, Inc. 的合併。根據協議條款，Barinthus 的股東將為每一股美國存托股份或普通股獲得新合併公司的一股普通股。如果您是 Barinthus 的股東， 請點擊這裏瞭解您的權利和選擇 。
Fifth Third Bancorp (NASDAQ: FITB) 與 Comerica Incorporated 的合併。在擬議交易完成後，Fifth Third 的股東將擁有合併公司約 73% 的股份。如果您是 Fifth Third 的股東，請點擊這裏瞭解您的法律權利和選擇。
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) 出售給 Eli Lilly and Company。根據擬議交易的條款，Adverum 的股東將獲得每股 3.56 美元的現金，以及一項不可轉讓的或有價值權利 (CVR)，持有人在達到兩個特定里程碑後可獲得額外的最高 8.91 美元現金。如果您是 Adverum 的股東， 請點擊這裏瞭解您的權利和選擇 。
Huntington Bancshares Incorporated (NASDAQ: HBAN) 與 Cadence Bank 的合併。如果您是 Huntington 的股東，請點擊這裏瞭解您的法律權利和選擇。
Halper Sadeh LLC 可能會為股東尋求增加的補償、關於擬議交易的額外披露和信息，或代表股東尋求其他救濟和利益。我們將以風險代理的方式處理此案，您無需承擔我們的法律費用或支出的自付費用。
鼓勵股東 免費 聯繫該公司以討論他們的法律權利和選擇。請致電 Daniel Sadeh 或 Zachary Halper，電話 (212) 763-0060，或發送電子郵件至 [email protected] 或 [email protected]。
Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
律師廣告。以往的結果並不保證類似的結果。
聯繫信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
來源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE5Jk5ld3NJdGVtSWQ9TlkyOTMzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTkxODE4UFJfTkVXU19VU1BSX19fX19OWTI5MzM4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE5Jk5ld3NJdGVtSWQ9TlkyOTMzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTkxODE4UFJfTkVXU19VU1BSX19fX19OWTI5MzM4"/>

BRNS

Adverum生物科技

HBAN

五三銀行

Halper Sadeh LLC 是一家投資者權益法律事務所，正在調查涉及 Barinthus Biotherapeutics、五三銀行、Adverum 生物科技和 Huntington Bancshares 的併購中可能違反聯邦證券法和信託責任的行為。鼓勵股東聯繫該事務所以討論他們的權利，因為 Halper Sadeh 可能會代表他們尋求增加對價、額外披露或其他救濟。該事務所以風險代理費用的方式運營，代表全球投資者處理證券欺詐和公司不當行為案件

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
<div class="lb-trans">股東應立即聯繫該公司，因為可能有限的時間來維護您的權利。
</div>, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
<div class="lb-trans">, /PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否可能違反聯邦證券法和/或對股東的信託責任。
</div>Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Barinthus Biotherapeutics plc (NASDAQ: BRNS) 與 Clywedog Therapeutics, Inc. 的合併。根據協議條款，Barinthus 的股東將為每一股美國存托股份或普通股獲得新合併公司的一股普通股。如果您是 Barinthus 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>Fifth Third Bancorp (NASDAQ: FITB)'s merger with Comerica Incorporated. Upon closing of the proposed transaction, Fifth Third shareholders will own approximately 73% of the combined company. If you are a Fifth Third shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Fifth Third Bancorp (NASDAQ: FITB) 與 Comerica Incorporated 的合併。在擬議交易完成後，Fifth Third 的股東將擁有合併公司約 73% 的股份。如果您是 Fifth Third 的股東，請點擊這裏瞭解您的法律權利和選擇。
</div>Adverum Biotechnologies, Inc. (NASDAQ: ADVM)'s sale to Eli Lilly and Company. Under the terms of the proposed transaction, Adverum shareholders will receive $3.56 per share in cash plus one non-transferrable contingent value right (CVR) entitling the holder to receive up to an additional $8.91 per CVR in cash upon the achievement of two certain milestones. If you are an Adverum shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Adverum Biotechnologies, Inc. (NASDAQ: ADVM) 出售給 Eli Lilly and Company。根據擬議交易的條款，Adverum 的股東將獲得每股 3.56 美元的現金，以及一項不可轉讓的或有價值權利 (CVR)，持有人在達到兩個特定里程碑後可獲得額外的最高 8.91 美元現金。如果您是 Adverum 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>Huntington Bancshares Incorporated (NASDAQ: HBAN)'s merger with Cadence Bank. If you are a Huntington shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Huntington Bancshares Incorporated (NASDAQ: HBAN) 與 Cadence Bank 的合併。如果您是 Huntington 的股東，請點擊這裏瞭解您的法律權利和選擇。
</div>Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">Halper Sadeh LLC 可能會為股東尋求增加的補償、關於擬議交易的額外披露和信息，或代表股東尋求其他救濟和利益。我們將以風險代理的方式處理此案，您無需承擔我們的法律費用或支出的自付費用。
</div>Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
<div class="lb-trans">鼓勵股東 免費 聯繫該公司以討論他們的法律權利和選擇。請致電 Daniel Sadeh 或 Zachary Halper，電話 (212) 763-0060，或發送電子郵件至 [email protected] 或 [email protected]。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律師廣告。以往的結果並不保證類似的結果。
</div>Contact Information:
<div class="lb-trans">聯繫信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">來源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMTE5Jk5ld3NJdGVtSWQ9TlkyOTMzOCZUcmFuc21pc3Npb25fSWQ9MjAyNTExMTkxODE4UFJfTkVXU19VU1BSX19fX19OWTI5MzM4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY29338&amp;Transmission_Id=202511191818PR_NEWS_USPR_____NY29338&amp;DateId=20251119"/>

Halper Sadeh LLC 鼓勵 Barinthus Biotherapeutics、五三銀行、Adverum 生物科技、Huntington Bancshares 的股東聯繫該公司以討論他們的權利